Peer Review History
Original SubmissionJanuary 27, 2020 |
---|
PONE-D-19-36024 A simplified method for blood feeding, oral infection, and saliva collection of the dengue vector mosquitoes PLOS ONE Dear Dr Tu, Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process. Please carefully check all the aspects both reviewers have raised around your manuscript, specially related to the writing. A thorough grammar review should be performed in the end after all other points have been addressed. We would appreciate receiving your revised manuscript by APRIL 10th. When you are ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file. If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. To enhance the reproducibility of your results, we recommend that if applicable you deposit your laboratory protocols in protocols.io, where a protocol can be assigned its own identifier (DOI) such that it can be cited independently in the future. For instructions see: http://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols Please include the following items when submitting your revised manuscript:
Please note while forming your response, if your article is accepted, you may have the opportunity to make the peer review history publicly available. The record will include editor decision letters (with reviews) and your responses to reviewer comments. If eligible, we will contact you to opt in or out. We look forward to receiving your revised manuscript. Kind regards, Luciano Andrade Moreira, PhD Academic Editor PLOS ONE Journal Requirements: When submitting your revision, we need you to address these additional requirements: 1. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at http://www.plosone.org/attachments/PLOSOne_formatting_sample_main_body.pdf and http://www.plosone.org/attachments/PLOSOne_formatting_sample_title_authors_affiliations.pdf 2. Thank you for stating the following in the Acknowledgments Section of your manuscript: "This study was supported by research grant (MOST 107-2313-B-005-027) from Ministry of Science and Technology, Executive Yuan, ROC. The authors thank Prof. Roger F. Hou, National Chung Hsing University, for critical reading of the manuscript." We note that you have provided funding information that is not currently declared in your Funding Statement. However, funding information should not appear in the Acknowledgments section or other areas of your manuscript. We will only publish funding information present in the Funding Statement section of the online submission form. Please remove any funding-related text from the manuscript and let us know how you would like to update your Funding Statement. Currently, your Funding Statement reads as follows: "No, the funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. " 3. Thank you for stating the following in the Methods Section of your manuscript: "The mouse strain BALB/c was a generous from Lexco Biotechnology Co., Ltd"." We note that you have provided funding information that is not currently declared in your Funding Statement. However, funding information should not appear in the Acknowledgments section or other areas of your manuscript. We will only publish funding information present in the Funding Statement section of the online submission form. Please remove any funding-related text from the manuscript and let us know how you would like to update your Funding Statement. Currently, your Funding Statement reads as follows: "No, the funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. " Additionally, because some of your funding information pertains to commercial funding, we ask you to provide an updated Competing Interests statement, declaring all sources of commercial funding. In your Competing Interests statement, please confirm that your commercial funding does not alter your adherence to PLOS ONE Editorial policies and criteria by including the following statement: "This does not alter our adherence to PLOS ONE policies on sharing data and materials.” as detailed online in our guide for authors http://journals.plos.org/plosone/s/competing-interests. If this statement is not true and your adherence to PLOS policies on sharing data and materials is altered, please explain how. Please include the updated Competing Interests Statement and Funding Statement in your cover letter. We will change the online submission form on your behalf. [Note: HTML markup is below. Please do not edit.] Reviewers' comments: Reviewer's Responses to Questions Comments to the Author 1. Is the manuscript technically sound, and do the data support the conclusions? The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented. Reviewer #1: Yes Reviewer #2: Yes ********** 2. Has the statistical analysis been performed appropriately and rigorously? Reviewer #1: Yes Reviewer #2: Yes ********** 3. Have the authors made all data underlying the findings in their manuscript fully available? The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified. Reviewer #1: Yes Reviewer #2: Yes ********** 4. Is the manuscript presented in an intelligible fashion and written in standard English? PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here. Reviewer #1: No Reviewer #2: No ********** 5. Review Comments to the Author Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters) Reviewer #1: In this manuscript, Sri-in et al propose a simple and elegant method for mosquito feeding under laboratory conditions. Different strategies, methods, and apparatus for mosquito feeding have been proposed along the past years, but usually they require a heat source or other labware. Here, the authors propose a simplified system using stretched parafilm to offer a blood or protein meal to mosquitoes. Their findings suggest that using wrapped blood inside parafilm is comparable to using mice as blood source for mosquito feeding regarding the number of engorged females and number of eggs laid per female. Also, it seems possible to recover saliva proteins and virus expelled in the saliva by infected mosquitoes using their proposed feeding system, enabling transmission experiments to be done in a simplified manner. Thus, this reviewer recommends the paper for publication with minor revision. Listed below are misunderstandings that must be fixed before publication, together with necessary clarification in methods and statistics. This reviewer will feel pleased to review the rebuttal of this manuscript upon resubmission. Major comments: Line 69-71 – […] “saliva collected does not contain sufficient virus titers for studying DENV transmission by means of plaque assay or mouse model.” […] – This affirmation is not entirely true. It is difficult to detect infected saliva from infected mosquitoes but is not impossible. Different studies have studied virus transmission using region-delimited mosquito biting in mouse ears (e.g. Secundino NFC et al, 2017 – doi 10.1186/s13071-017-2286-2 or Cox J et al, 2012 – doi 10.1128/JVI.00534-12). In fact, it is discussed later on in the text that their method is only suitable for collection of saliva from pools of at least 20 mosquitoes (Fig 2 C/D – Lines 210-214) thus a comparison with other methods should be discussed in the text. Line 219-232 – Would have the authors verified the prevalence of DENV infection in individual mosquitoes upon feeding on their system comparing to a water-jacked or other previously characterized system? Their assessment of saliva detection of DENV was done in large pools of mosquitoes but could only represent a very low percentage of mosquitoes that were infected, thus representing that their system may not be efficient to infect mosquitoes. The authors even emphasize that their results “indicated that the artificial blood feeder is an efficient artificial feeder” (lines 231-232) and their results do not hold sufficient information for this affirmation. Also, it is interesting to include more details (e.g. size of mosquito pool) of the saliva DENV-detection experiment in the figure legend. Minor comments: For a better organization of the paper, I suggest moving Tables to supplementary information. Line 66 – Break into a new paragraph. Ideas are not connected with previous lines. Line 98 – Please add sentence explaining that plaque assay method will be further explained in the text. Line 100 – Invert “laying eggs” by “egg laying” Line 148 – “The infected mosquitoes were allowed to salivate for 30 min.” – Mosquitoes did not salivate; they were allowed to bite the candy wrap. Please rephrase. Line 150 – “5 times” not “5 time” Line 154 – Describe better “Millipore column measuring 3 kDa” Line 159-160 – Is it correct that plaque assay was done using C6/36 cells? Usually these cells do not form plaques upon DENV infection, thus should not be possible to visualize using crystal violet. Please clarify. Line 173 – change “elucidate” by “evaluate if there is” Line 175 – “…albopictus were fed on” by “…albopictus were allowed to feed on” Line 178 – Was it considered fully engorged females or mosquitoes that ingested any amount of blood? Please clarify. Line 183-184 – “This result may …” This sentence brings no relevant information. Please rephrase. Line 193 and 198 – Is reference 11 correct here? Line 193-196 – Please clarify that only for Ae. aegypti you found significantly higher percentage of mosquitoes fed on parafilm candy. Line 199 – The discussion starting by “In addition” is important but is lacking context on the way it’s written. Please explain or rephrase. Line 208 – “engorged” not “engorge” Line 215-216 – Please rephrase Line 230 – What is high virus concentration? Line 230-231 – Explain the sentence “Interestingly, the infected saliva collection…” Line 233 – Lost discussion in the text. Please include context and rephrase. Table 4 – What means “a” along the statistics represented in this table? Reviewer #2: I feel that this is good paper describing a low cost alternative to standard artificial blood-feeder devices that are commercially available. The finding presented here validate this new method as an acceptable alternative, I believe these findings will have a great impact on the ability for labs in lower income countries to be able to perform more complex vector competence and transmission studies. The only issue that I have found with this article is language based, there are several instances throughout the paper in which the phrasing used is confusing and hard to understand the point being made. I have highlighted these sections in my review of the article and believe that the correction of these minor issues will make for a good article. ********** 6. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy. Reviewer #1: No Reviewer #2: No [NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files to be viewed.] While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email us at figures@plos.org. Please note that Supporting Information files do not need this step.
|
Revision 1 |
A simplified method for blood feeding, oral infection, and saliva collection of the dengue vector mosquitoes PONE-D-19-36024R1 Dear Dr. Tu, We are pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it complies with all outstanding technical requirements. Please check that are still some comments from both reviewers which might improve your final manuscript. Within one week, you will receive an e-mail containing information on the amendments required prior to publication. When all required modifications have been addressed, you will receive a formal acceptance letter and your manuscript will proceed to our production department and be scheduled for publication. Shortly after the formal acceptance letter is sent, an invoice for payment will follow. To ensure an efficient production and billing process, please log into Editorial Manager at https://www.editorialmanager.com/pone/, click the "Update My Information" link at the top of the page, and update your user information. If you have any billing related questions, please contact our Author Billing department directly at authorbilling@plos.org. If your institution or institutions have a press office, please notify them about your upcoming paper to enable them to help maximize its impact. If they will be preparing press materials for this manuscript, you must inform our press team as soon as possible and no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org. With kind regards, Luciano Andrade Moreira, PhD Academic Editor PLOS ONE Additional Editor Comments (optional): Reviewers' comments: Reviewer's Responses to Questions Comments to the Author 1. If the authors have adequately addressed your comments raised in a previous round of review and you feel that this manuscript is now acceptable for publication, you may indicate that here to bypass the “Comments to the Author” section, enter your conflict of interest statement in the “Confidential to Editor” section, and submit your "Accept" recommendation. Reviewer #1: All comments have been addressed Reviewer #2: (No Response) ********** 2. Is the manuscript technically sound, and do the data support the conclusions? The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented. Reviewer #1: Yes Reviewer #2: Yes ********** 3. Has the statistical analysis been performed appropriately and rigorously? Reviewer #1: Yes Reviewer #2: Yes ********** 4. Have the authors made all data underlying the findings in their manuscript fully available? The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified. Reviewer #1: Yes Reviewer #2: Yes ********** 5. Is the manuscript presented in an intelligible fashion and written in standard English? PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here. Reviewer #1: Yes Reviewer #2: Yes ********** 6. Review Comments to the Author Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters) Reviewer #1: The authors addressed reviewers’ comments, and the paper is sound for publication according to this reviewer. Of note, the revised manuscript with Track Changes did not match the final PDF version, which made reviewing a complicated process. Some minor suggestions to improve clarity in the final text: Line 200-202 – “Our results revealed that the number of engorged Ae. aegypti and Ae. albopictus fed using the artificial feeder showed significantly increased protein concentration (…)”. Suggestion: “Our results revealed that the amount of protein detected in the artificial feeding solution increased according to the number of Ae. aegypti and Ae. albopictus that were engorged after exposure to the device (…)”. Line 208-209 – “The most appropriate time to collect infected mosquito saliva was examined on day 3, 5, 7, 10 and 14 post infectious blood meal.” – Suggestion: “We collected and evaluated DENV infection in mosquitoes’ saliva on days 3, 5, 7, 10 and 14 post infectious blood meal.” Line 211 – “…device engorged” to “…device reached full engorgement”. Line 221-222 – “Using our method, the saliva was collected sufficient virus titer for studying DENV transmission by plaque assay (…)”. Suggestion: “Using our method, the collected saliva had sufficient virus titer for studying DENV transmission by plaque assay (…)”. Reviewer #2: I still feel that this paper describing a novel low cost artificial blood-feeder is good and merits publication. The authors present methods utilized to validate this alternative blood feeding system, which has the potential to greatly impact the ability for labs in lower income countries to be able to perform more complex vector competence and transmission studies. I have found this version to be much improved compared to the original submission, with much clearer language which it made it easier to follow. I did have a few minor critiques for this version which are not critical, however there were a couple of spots that I felt needed a little more clarification to make this a more polished article. With that said I look forward to this article to be published and utilized by labs with limited financial support. ********** 7. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy. Reviewer #1: No Reviewer #2: No |
Formally Accepted |
PONE-D-19-36024R1 A simplified method for blood feeding, oral infection, and saliva collection of the dengue vector mosquitoes Dear Dr. Tu: I am pleased to inform you that your manuscript has been deemed suitable for publication in PLOS ONE. Congratulations! Your manuscript is now with our production department. If your institution or institutions have a press office, please notify them about your upcoming paper at this point, to enable them to help maximize its impact. If they will be preparing press materials for this manuscript, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information please contact onepress@plos.org. For any other questions or concerns, please email plosone@plos.org. Thank you for submitting your work to PLOS ONE. With kind regards, PLOS ONE Editorial Office Staff on behalf of Dr. Luciano Andrade Moreira Academic Editor PLOS ONE |
Open letter on the publication of peer review reports
PLOS recognizes the benefits of transparency in the peer review process. Therefore, we enable the publication of all of the content of peer review and author responses alongside final, published articles. Reviewers remain anonymous, unless they choose to reveal their names.
We encourage other journals to join us in this initiative. We hope that our action inspires the community, including researchers, research funders, and research institutions, to recognize the benefits of published peer review reports for all parts of the research system.
Learn more at ASAPbio .